ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 103 filers reported holding ADICET BIO INC in Q3 2022. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,719,930 | -46.0% | 2,715,278 | -4.2% | 0.26% | -54.5% |
| Q2 2023 | $6,888,719 | -62.0% | 2,834,864 | -9.8% | 0.57% | -73.2% |
| Q1 2023 | $18,107,182 | -35.6% | 3,143,608 | 0.0% | 2.13% | -27.6% |
| Q4 2022 | $28,103,855 | -19.1% | 3,143,608 | +28.7% | 2.94% | -11.6% |
| Q3 2022 | $34,743,000 | -2.6% | 2,443,246 | -0.0% | 3.32% | -3.5% |
| Q2 2022 | $35,679,000 | +19.1% | 2,443,780 | +62.9% | 3.45% | +19.5% |
| Q1 2022 | $29,956,000 | – | 1,500,055 | – | 2.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $30,017,000 | 10.26% |
| Foresite Capital Management V, LLC | 680,000 | $9,670,000 | 7.44% |
| Foresite Capital Opportunity Management V, LLC | 170,000 | $2,417,000 | 7.26% |
| DAFNA Capital Management LLC | 935,766 | $13,307,000 | 3.58% |
| COWEN AND COMPANY, LLC | 2,443,246 | $34,743,000 | 3.32% |
| JOHNSON & JOHNSON | 728,944 | $10,366,000 | 3.05% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $8,248,000 | 2.99% |
| Ally Bridge Group (NY) LLC | 244,400 | $3,475,000 | 2.29% |
| Orbimed Advisors | 7,447,140 | $105,898,000 | 1.97% |
| Cormorant Asset Management, LP | 1,400,000 | $19,908,000 | 1.39% |